Jefferies Initiates Coverage On Tango Therapeutics with Buy Rating, Announces Price Target of $19
Portfolio Pulse from Benzinga Newsdesk
Jefferies has initiated coverage on Tango Therapeutics (NASDAQ:TNGX) with a Buy rating and a price target of $19.
July 17, 2024 | 12:45 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies has initiated coverage on Tango Therapeutics with a Buy rating and a price target of $19.
The initiation of coverage with a Buy rating and a specific price target of $19 by a reputable analyst from Jefferies is likely to positively influence investor sentiment and drive short-term price appreciation for Tango Therapeutics.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100